The Institutional Response to Untreatable Infection: Asepsis Maximalism in the Postwar Era?

The institutional response to untreatable infection in the postwar era began as a coordinated crisis. The Bacillary Congress of Geneva in 1952 formalized asepsis maximalism as the only available strategy against systemic bacterial disease, but the practical work of rebuilding medicine around this doctrine fell to thousands of hospitals, ministries, and technical agencies across the world's industrialized nations. What followed was not a sudden transformation but a sustained institutional remapping that lasted through the 1960s and 1970s, reshaping hospital architecture, surgical practice, public health authority, and the entire industrial base that supplied medical settings with equipment and materials.

The first requirement was standardization. The Geneva Sanitary Bureau, established immediately after the Congress, faced the problem that infection-control protocols varied wildly between nations and even between hospitals in the same city. A surgical suite in Stockholm operated under different assumptions than one in Vienna. Water standards differed. The handling of contaminated textiles had no agreed procedure. The Bureau's early work was administrative drudgery: collecting data on infection rates from hospitals willing to report them, comparing surgical outcomes against infection control variables, drafting model protocols that could be adopted across borders. By 1956, the Geneva Sanitary Bureau had published its first comprehensive Handbook of Coordinated Asepsis, a document that would become, in various national revisions, the foundation of postwar infection-control architecture.

Hospital design changed radically. Before 1952, hospitals had been designed for flow and economy. The clean ward concept was new and experimental—a physically segregated unit in which air was filtered and humidity controlled, surfaces were sealed and non-porous, and patient admission required a sequence of barriers and decontamination steps. The clean wards that emerged after 1952 were built as fortifications. The Berlin Teaching Hospital Project, a major experimental facility completed in 1965 under the direction of Richard Reinhardt, isolated surgical theatres with positive air pressure, installed HEPA filtration, and replaced wood and plaster with seamless epoxy and stainless steel. When the hospital opened, its infection rates fell to less than half those of conventional wards—a result that, though marginal by the standards of a world with reliable antibacterial drugs, was revolutionary in this one, and triggered a wave of rebuilding across Europe and North America.

This architectural transformation created enormous demand for new materials and equipment. The disposable textile industry, which had existed in small form before the war, exploded into a major manufacturing sector. Paper surgical gowns, single-use gloves, sterile drapes, and disposable instruments became standard in clean wards. By the 1960s, the volume of disposable material flowing through hospitals was enormous, and the industry became politically significant in every major industrial nation. Manufacturers competed fiercely for contracts, and the supply chain—from pulp mills to sterilization facilities to hospital purchasing—was tightly regulated by government bodies that had no equivalent in the previous medical era. The cost was staggering. Hospital material expenditure in the United States rose from roughly 8 percent of total hospital spending in 1950 to nearly 25 percent by 1975, driven almost entirely by disposable materials and specialized environmental equipment.

The institutional authority of public health agencies grew in lockstep with these technical changes. Governments that had treated medicine as a largely private concern began to treat infection control as a matter of state security. The Geneva Sanitary Bureau gained real power over quarantine decisions and disease notification. Water authorities in every developed nation were placed under medical supervision for the first time, with bacteriologists gaining authority over municipal supply systems. Food inspection agencies were reorganized, usually under medical rather than agricultural oversight. By the 1970s, the notion that infection control was a public health matter rather than a clinical question was so embedded that few institutions questioned it.

Serum therapy research was also institutionalized. The Infectious Disease Research Centre in Cambridge, established in 1968, became the model for postwar institutions devoted to the only viable systemic treatment alternative to azo drugs. Similar centres were founded in Paris, Tokyo, and Melbourne. These were expensive, highly specialized facilities requiring herds of hyperimmunized animals, sophisticated laboratory equipment, and teams of researchers trained in both bacteriology and immunology. The International Serum Registry, established in 1975, coordinated donor serum stocks across nations and standardized the measurement of serum therapy outcomes using newly developed survival analysis methods. By the end of the 1970s, serum therapy had moved from the margins to the centre of medical practice for untreatable systemic infection, supported by substantial government funding and international coordination.

What did not change was the underlying problem. Bacterial infection remained incurable by chemical means. The azo drugs remained the only systemic antibacterial compounds available, and their efficacy against resistant organisms did not improve. Bacterial genetics, established as a serious field by Joshua Lederberg and others, revealed why: bacteria could inherit and select for resistance traits through natural variation, and no single chemical agent could be relied upon to kill all strains of a given pathogen. This meant that the institutional innovations of the postwar era—the clean wards, the protocols, the public health authority, the serum research apparatus—were permanent solutions to a permanent problem. They were not temporary measures awaiting better chemistry. They were the actual shape medicine would take in a world without reliable systemic antibacterial treatment.